Zenas BioPharma Inc.(ZBIO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ZBIO Zenas BioPharma Inc.

交易中 11-15 13:22:26 EST

17.45

-1.28

-6.83%

最高19.50	最低17.43	成交量7.51万
今开18.58	昨收18.73	日振幅11.07%
总市值7.29亿	流通市值4.71亿	总股本4,178万
成交额135.83万	换手率0.28%	流通股本2,699万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ZBIO","market":"US","secType":"STK","nameCN":"Zenas BioPharma Inc.","latestPrice":17.45,"timestamp":1731694766471,"preClose":18.73,"halted":0,"volume":75058,"delay":0,"floatShares":26985357,"shares":41777675,"eps":-10.709045,"marketStatus":"交易中","marketStatusCode":2,"change":-1.28,"latestTime":"11-15 13:22:26 EST","open":18.58,"high":19.5,"low":17.4275,"amount":1358319.597114,"amplitude":0.110651,"askPrice":17.83,"askSize":8,"bidPrice":17.45,"bidSize":36,"shortable":3,"etf":0,"ttmEps":-10.709045,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1731704400000},"adr":0,"listingDate":1726200000000,"adjPreClose":18.73,"adrRate":0,"sharesOutstanding":249967,"nav":10.0592,"aum":2514468.0464,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":18.73,"preClose":18.73,"latestTime":"16:00 EST","volume":559,"amount":10470.07,"timestamp":1731618005218},"volumeRatio":1.748782},"requestUrl":"/m/hq/s/ZBIO","defaultTab":"news","newsList":[{"id":"1136169257","title":"异动解读 | 生物科技新星Zenas BioPharma首秀大涨11.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=1136169257","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1136169257?lang=zh_cn&edition=full","pubTime":"2024-09-14 01:00","pubTimestamp":1726246829,"startTime":"0","endTime":"0","summary":"今日,生物科技公司Zenas BioPharma Inc. 在纳斯达克成功完成IPO,股价大涨11.71%,引发市场关注。当日Zenas IPO发行价为17美元,开盘股价则为18.35美元,较发行价溢价8%。Zenas在本次IPO中发行1320万股,募集资金2.25亿美元,超过了原计划规模。随着美国IPO新股市场近期回温,投资者对Zenas这样前景可期的生物科技股青睐有加,均有望成为推动其当日首秀股价大涨的重要原因。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ZBIO"],"gpt_icon":0},{"id":"2467270506","title":"更新 2-Zenas 生物制药公司首次上市股价上涨近 8","url":"https://stock-news.laohu8.com/highlight/detail?id=2467270506","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467270506?lang=zh_cn&edition=full","pubTime":"2024-09-14 00:58","pubTimestamp":1726246693,"startTime":"0","endTime":"0","summary":"     路透9月13日 - 百时美施贵宝支持的Zenas生物制药公司  周五在纳斯达克首次公开发行股票 ，股价上涨近8%，这是2024年美国首次公开发行股票市场 在经历两年低迷后复苏的一个迹象。投资者对医疗支付公司 Waystar   和临床生物制药公司 CG Oncology   等公司反应热烈，截至上次收盘，这两家公司的交易价格均高于其 IPO 价格。Zenas与Bicara Therapeutics   和生物技术公司MBX Biosciences   同时上市，因为IPO活动在经历了夏季的低迷后有所回升。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1162221912.USD","IE00BZ1G4Q59.USD","CGON","LU1093756325.SGD","LU0225771236.USD","BK4007","IPO","LU1989772840.SGD","IE0002141913.USD","LU0267386448.USD","LU0237698245.USD","LU1989772923.USD","LU1074936037.SGD","LU1291159041.SGD","LU2360032135.SGD","LU0321505439.SGD","LU1261432733.SGD","BK4167","LU0106831901.USD","BCAX","BK4585","IE00BJJMRZ35.SGD","IE00BSNM7G36.USD","LU0320765646.SGD","LU0321505868.SGD","LU0061475181.USD","SLE","BMY","LU1720051017.SGD","LU2242646821.SGD","LU1548497426.USD","BK4077","WAY","LU1585245621.USD","BK4127","BK4532","LU1571399168.USD","BK4534","LU2125154778.USD","BK4559","LU0098860793.USD","LU1093756168.USD","IE00BJT1NW94.SGD","ZBIO","LU1989771016.USD","LU0882574055.USD","LU2357305700.SGD","LU0868494617.USD","LU2125154935.USD"],"gpt_icon":0},{"id":"2461559514","title":"免疫疗法开发商Zenas BioPharma(ZBIO.US)申请在美上市 拟筹资1亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2461559514","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461559514?lang=zh_cn&edition=full","pubTime":"2024-08-23 16:23","pubTimestamp":1724401439,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，免疫疗法开发商Zenas BioPharma周四向美国证券交易委员会提交了首次公开募股申请，计划融资1亿美元。资料显示，Zenas BioPharma是一家专注于为患者开发免疫疗法的公司，拥有从早期到晚期临床项目设计和执行的广泛临床专业知识。目前，该药物正在针对多种适应症进行临床试验评估。数据显示，该公司截至2024年6月30日的12个月收入为5000万美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1169279.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["ZBIO"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.zenasbio.com","stockEarnings":[{"period":"1week","weight":-0.1047},{"period":"1month","weight":-0.0512},{"period":"3month","weight":0.1018},{"period":"ytd","weight":0.1018}],"compareEarnings":[{"period":"1week","weight":-0.0038},{"period":"1month","weight":0.0234},{"period":"3month","weight":0.0704},{"period":"6month","weight":0.1207},{"period":"1year","weight":0.3195},{"period":"ytd","weight":0.2483}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Zenas BioPharma, Inc.最初于2019年11月12日在开曼注册成立，名称为Zenas BioPharma（开曼）Limited。2023年8月2日，该公司在特拉华州成立，同时将其名称从Zenas BioPharma（Cayman）Limited更改为Zenas BioPharma, Inc.。他们是一家临床阶段的全球生物制药公司，致力于为有需要的患者开发和商业化基于免疫的变革疗法。随着对自身免疫性疾病发病机制的不断了解，以及有前景的基于免疫学的药理学靶点的扩展，他们正在建立一家专注于免疫学和炎症（“I&I”）的生物制药公司。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.066193},{"month":2,"riseRate":0.4,"avgChangeRate":-0.014847},{"month":3,"riseRate":0.6,"avgChangeRate":-0.027723},{"month":4,"riseRate":0.5,"avgChangeRate":0.001823},{"month":5,"riseRate":0.75,"avgChangeRate":0.218705},{"month":6,"riseRate":0.25,"avgChangeRate":-0.082782},{"month":7,"riseRate":0.2,"avgChangeRate":-0.126333},{"month":8,"riseRate":0.6,"avgChangeRate":0.033743},{"month":9,"riseRate":0.5,"avgChangeRate":0.044898},{"month":10,"riseRate":0.6,"avgChangeRate":0.128289},{"month":11,"riseRate":0,"avgChangeRate":-0.164546},{"month":12,"riseRate":0.4,"avgChangeRate":0.053544}],"exchange":"NASDAQ","name":"Zenas BioPharma Inc.","nameEN":"Zenas BioPharma Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Zenas BioPharma Inc.(ZBIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Zenas BioPharma Inc.(ZBIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Zenas BioPharma Inc.,ZBIO,Zenas BioPharma Inc.股票,Zenas BioPharma Inc.股票老虎,Zenas BioPharma Inc.股票老虎国际,Zenas BioPharma Inc.行情,Zenas BioPharma Inc.股票行情,Zenas BioPharma Inc.股价,Zenas BioPharma Inc.股市,Zenas BioPharma Inc.股票价格,Zenas BioPharma Inc.股票交易,Zenas BioPharma Inc.股票购买,Zenas BioPharma Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Zenas BioPharma Inc.(ZBIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Zenas BioPharma Inc.(ZBIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}